Officials could communicate the committee's advice from the meeting, as has happened in the past, and the minister could act accordingly. That could involve accepting the advice, making a decision to ensure patients maintain reimbursed access, as he has prioritised, or both. Probably best to resolve it quickly for patients.
It might make sense to follow the process, mostly, but no need to keep patients waiting
July 9, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Novo Nordisk backs care for rural health professionals in southern NSW
August 19, 2026 - - Latest News -
Opportunity #3 - finally deliver on the repeated claims of patient-centricity
August 19, 2026 - - Latest News -
Departmental restructure formally splits medicines financing from pharmacy services
August 19, 2026 - - Latest News -
Wesfarmers Health evolves its loyalty program with new Pulse Rewards
August 19, 2026 - -
CSL absorbs loss in reset year as investors back its plasma-led recovery
August 18, 2026 - - Latest News -
Opportunity #2 - AI can democratise HTA and the negotiations must not squander it
August 18, 2026 - - Latest News -
Opportunity #1 - biosimilar policy failure has become impossible to ignore
August 18, 2026 - - Latest News

